Keith A A Fox
Overview
Explore the profile of Keith A A Fox including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
482
Citations
22140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeymer U, Bauersachs R, Dagkonakis N, Sebastian Debus E, Herold J, Anand S, et al.
Clin Res Cardiol
. 2025 Feb;
PMID: 39930161
Aims: To determine characteristics and clinical outcomes of German patients with coronary artery disease (CAD) with or without peripheral artery disease (PAD) who initiated dual pathway inhibition (DPI) using rivaroxaban...
2.
Chapman A, Taggart C, Boeddinghaus J, Mills N, Fox K
Eur Heart J
. 2024 Dec;
46(6):504-517.
PMID: 39658094
The Fourth Universal Definition of Myocardial Infarction recommends a classification based on aetiology, in recognition that the underlying pathophysiology of myocardial infarction influences the approach to investigation and treatment. Type...
3.
Camm C, Virdone S, Jerjes-Sanchez C, Oh S, Eikelboom J, Oto A, et al.
Int J Cardiol
. 2024 Dec;
421():132866.
PMID: 39631531
Objective: To determine whether stroke prevention strategy, comorbidity management, and clinical outcome risks differ across atrial fibrillation (AF) care specialties. Methods: Newly diagnosed non-valvular AF patients enrolled in the international,...
4.
Kunadian V, Mossop H, Shields C, Bardgett M, Watts P, Teare M, et al.
N Engl J Med
. 2024 Sep;
391(18):1673-1684.
PMID: 39225274
Background: Whether a conservative strategy of medical therapy alone or a strategy of medical therapy plus invasive treatment is more beneficial in older adults with non-ST-segment elevation myocardial infarction (NSTEMI)...
5.
Sebastian Debus E, Aboyans V, Bosch J, Fox K, Patel M, Welsh R, et al.
Eur J Vasc Endovasc Surg
. 2024 Jul;
68(6):784-795.
PMID: 39009110
Objective: To assess the characteristics and clinical outcomes of patients with lower extremity peripheral artery disease (PAD) in XATOA receiving dual pathway inhibition (DPI) with rivaroxaban 2.5 mg twice daily...
6.
Himmelreich J, Virdone S, Camm J, Pieper K, Harskamp R, Oto A, et al.
Open Heart
. 2024 Jul;
11(2).
PMID: 38955399
Background: The extent to which differences in results from Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) and Rivaroxaban Once Daily Oral Direct Factor Xa...
7.
Forbes N, Yi Q, Moayyedi P, Bosch J, Bhatt D, Fox K, et al.
Aliment Pharmacol Ther
. 2024 Jul;
60(6):737-748.
PMID: 38952045
Background: The incidence of major gastrointestinal bleeding (GIB) in patients on low-dose direct-acting oral anticoagulants (DOACs) is relatively unknown. Estimates from randomised controlled trials (RCTs) are lacking. Aims: To assess...
8.
Harrington J, Hellkamp A, Mahaffey K, Breithardt G, Halperin J, Hankey G, et al.
J Am Heart Assoc
. 2024 May;
13(11):e028951.
PMID: 38780169
Background: Days alive out of hospital (DAOH) is an objective and patient-centered net benefit end point. There are no assessments of DAOH in clinical trials of interventions for atrial fibrillation...
9.
Breitenstein A, Gay A, Vogtlander K, Fox K, Steffel J
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610724
: In the COMPASS trial, the combination of acetylsalicylic acid (ASA) plus 2.5 mg rivaroxaban twice daily (dual-pathway inhibition, DPI) has been shown to be superior to ASA monotherapy for...
10.
Kotanidis C, Mills G, Bendz B, Berg E, Hildick-Smith D, Hirlekar G, et al.
Eur Heart J
. 2024 Apr;
45(23):2052-2062.
PMID: 38596853
Background And Aims: Older patients with non-ST-elevation acute coronary syndrome (NSTEACS) are less likely to receive guideline-recommended care including coronary angiography and revascularization. Evidence-based recommendations regarding interventional management strategies in...